Upgrade to SI Premium - Free Trial

Jefferies Cuts Price Target on Celgene (CELG) as FX Weighs on Near-Term

January 29, 2016 9:07 AM
Jefferies maintained a Buy rating on Celgene (NASDAQ: CELG), and cut the price target to $146.00 (from $149.00), following the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles